Skip to content

Inogen INGN Inventory write-downs

Inventory write-downs at other companies

Pulmonx Corporation logo
Pulmonx CorporationLUNG
$144K+413%

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-7.6%
Enterprise value$98.45M-5.8%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's inventory write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's inventory write-downs?
Inogen (INGN) reported inventory write-downs of $416K in Q1 2026.
How has Inogen's inventory write-downs changed year-over-year?
Inogen's inventory write-downs increased by 150.6% year-over-year, from $166K to $416K.
What is the long-term trend for Inogen's inventory write-downs?
Over 4 years (2021 to 2025), Inogen's inventory write-downs has grown at a -20.5% compound annual growth rate (CAGR), from $2.06M to $822K.
What does inventory write-downs mean?
The non-cash expense recognized when the carrying value of inventory exceeds its net realizable value due to obsolescence, damage, or market price declines. This metric highlights inventory management effectiveness and potential risks in the supply chain. Frequent write-downs suggest poor demand forecasting or inventory aging issues.